University of California, San Diego
San Diego, California, 92103, United States
NCT Number: NCT03177655
This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
San Diego, California, 92103, United States
Interventions: Participants were assigned in alternate order to 10 weekly 1-hour sessions "Healing Light Guided Imagery" or at-home positive journaling; drop-outs were replaced.
Intervention Type: Behavioral
Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system). Because nerves in any part of the brain or spinal cord may be damaged, patients with multiple sclerosis can have symptoms in different parts of the body. Many Multiple Sclerosis patients suffer from depression, fatigue and anxiety in addition to physical symptoms. Drugs prescribed for MS have been shown to not improve these comorbid psychological symptoms. Researchers have shown that mindfulness-based training programs can help MS patients, but these therapies are highly resource demanding and taxing for those involved. "Healing Light" Guided Imagery (HLGI; supplementary materials) is a guided imagery therapy that simulates a self-hypnotic trance state that has been anecdotally shown to improve depression and fatigue in patients with MS in less time and with fewer support resources. The investigators plan to test whether HLGI can increase patient well-being.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participant exclusion criteria:
Guided Imagery meditation
Keeping a journal
Time frame: Change from baseline at 10 weeks
Quality of Life based on Multiple Sclerosis Quality of Life Instrument (MS-QOL-54)
Time frame: Change from baseline at 10 weeks
Depressed mood based on the Beck Depression Inventory II (BDI-II)
Time frame: Change from baseline at 10 weeks
Fatigue levels based on the Fatigue Severity Scale (FSS)
University of California, San Diego
Other
Acronym: HLGI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04777539
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Strasbourg, Bas-Rhin, France
View Trial DetailsNCT07195110
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Cairo, Egypt
View Trial DetailsNCT06583967
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Beersheba, Israel
View Trial DetailsNCT03972306
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Aurora, Colorado, United States
View Trial Details